Research suggests that graviola (Annona muricata) may possess anti-inflammatory and antioxidant properties based on a small body of preclinical evidence, including a 2018 narrative review and several animal and cell-based studies. Studies indicate that leaf extracts have shown protective effects against gastric ulcers in rats, supported wound healing through antioxidant and putative anti-inflammatory mechanisms, and demonstrated cytotoxic activity against cancer cells in laboratory conditions, with the overall direction of findings being generally supportive but limited in scope. All available evidence comes from in vitro cell studies, rat models, and a review of preclinical literature, with no published human clinical trials or randomized controlled trials identified, which represents a significant limitation in drawing conclusions about effectiveness or safety in people. The 2018 review itself acknowledged that rigorous safety studies are still needed, and while the preclinical data are described as promising, they do not yet establish graviola as a proven anti-inflammatory intervention for human use.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Emerging therapeutic potential of graviola and its constituents in cancers. | Review | 2018 | Supports | 100 |
| Antiproliferative activity of ionic liquid-graviola fruit extract against hum... | Other | 2019 | Neutral | 95 |
| Gastroprotective activity of Annona muricata leaves against ethanol-induced g... | Other | 2014 | Supports | 90 |
| Annona muricata leaves accelerate wound healing in rats via involvement of Hs... | Other | 2015 | Supports | 85 |